Abstract

BackgroundMissing data are a common problem in prospective studies with a long follow-up, and the volume, pattern and reasons for missing data may be relevant when estimating the cost of illness. We aimed to evaluate the effects of different methods for dealing with missing longitudinal cost data and for costing caregiver time on total societal costs in Alzheimer’s disease (AD).MethodsGERAS is an 18-month observational study of costs associated with AD. Total societal costs included patient health and social care costs, and caregiver health and informal care costs. Missing data were classified as missing completely at random (MCAR), missing at random (MAR) or missing not at random (MNAR). Simulation datasets were generated from baseline data with 10–40 % missing total cost data for each missing data mechanism. Datasets were also simulated to reflect the missing cost data pattern at 18 months using MAR and MNAR assumptions. Naïve and multiple imputation (MI) methods were applied to each dataset and results compared with complete GERAS 18-month cost data. Opportunity and replacement cost approaches were used for caregiver time, which was costed with and without supervision included and with time for working caregivers only being costed.ResultsTotal costs were available for 99.4 % of 1497 patients at baseline. For MCAR datasets, naïve methods performed as well as MI methods. For MAR, MI methods performed better than naïve methods. All imputation approaches were poor for MNAR data. For all approaches, percentage bias increased with missing data volume. For datasets reflecting 18-month patterns, a combination of imputation methods provided more accurate cost estimates (e.g. bias: −1 % vs −6 % for single MI method), although different approaches to costing caregiver time had a greater impact on estimated costs (29–43 % increase over base case estimate).ConclusionsMethods used to impute missing cost data in AD will impact on accuracy of cost estimates although varying approaches to costing informal caregiver time has the greatest impact on total costs. Tailoring imputation methods to the reason for missing data will further our understanding of the best analytical approach for studies involving cost outcomes.Electronic supplementary materialThe online version of this article (doi:10.1186/s12874-016-0188-1) contains supplementary material, which is available to authorized users.

Highlights

  • Missing data are a common problem in prospective studies with a long follow-up, and the volume, pattern and reasons for missing data may be relevant when estimating the cost of illness

  • When data were missing completely at random (MCAR), the naïve imputation performed as well as the more complicated multiple imputation (MI) Markov chain Monte Carlo (MCMC) method; for complete cases, the rate of bias ranged from −0.03 % with 10 % missing data to 4 % with 40 % missing data; for MI MCMC, the rate of bias ranged from 2 % with 10 % missing data to 15 % with 40 % missing data

  • When data were missing at random (MAR), the MI MCMC method performed better at 10–30 % missing data when compared with the complete case analysis

Read more

Summary

Introduction

Missing data are a common problem in prospective studies with a long follow-up, and the volume, pattern and reasons for missing data may be relevant when estimating the cost of illness. Many studies of people with Alzheimer’s disease (AD) determine disease-related costs through cross-sectional analysis or from retrospective databases Such studies do not account for missing cost data, which can lead to bias and reduce the statistical power to detect effects [1, 2]. About 20 % of patients drop out of a longitudinal AD study each year [2] and, in the GERAS observational study [4], 32.4 and 50.6 % of patients discontinued over 18 and 36 months, respectively (data on file) Such dropout can be associated with various patient factors, including poor cognitive performance or impaired functional ability due to worsening disease status, comorbid medical illness, as well as hospitalisation, institutionalisation or death [2, 5]. Loss of the caregiver from the study due to death, illness, increased burden or a change in caregiver will result in cost and resource use data not being collected

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call